Xiao Li Zhao

Changchun BioXun Biotech Co., Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic reagents. Its products include detection cards for blood types, coombs, and neonatal hemolytic disease, eluting agents, quality controls for screening and cross-matching, medical centrifuges, and reagent card incubators. The company was founded on July 16, 2001 and is headquartered in Changchun, China.

Changchun BioXun Biotech Co., Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic reagents. Its products include detection cards for blood types, coombs, and neonatal hemolytic disease, eluting agents, quality controls for screening and cross-matching, medical centrifuges, and reagent card incubators. The company was founded on July 16, 2001 and is headquartered in Changchun, China.

Nanyang Orthopedics High-Tech Zone Hospital Co., Ltd. engages in the operation of hospitals; provision of medical treatment as well as related technical consultation and technical services; sale of medicines, Class I, II, and III medical devices, as well as medical consumables; and lease of housings and equipment. The company was founded on April 21, 2014 and is headquartered in Nanyang, China.

Changchun BioXun Biotech Co., Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic reagents. Its products include detection cards for blood types, coombs, and neonatal hemolytic disease, eluting agents, quality controls for screening and cross-matching, medical centrifuges, and reagent card incubators. The company was founded on July 16, 2001 and is headquartered in Changchun, China.

Changchun BioXun Biotech Co., Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic reagents. Its products include detection cards for blood types, coombs, and neonatal hemolytic disease, eluting agents, quality controls for screening and cross-matching, medical centrifuges, and reagent card incubators. The company was founded on July 16, 2001 and is headquartered in Changchun, China.

Zibo Hongxin Medical Technology Co., Ltd. engages in the research and development, and sale of medical devices. It also involves in the investment in medical device and medical service industries. The company was founded on July 8, 2016 and is headquartered in Zibo, China.

Changchun BioXun Biotech Co., Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic reagents. Its products include detection cards for blood types, coombs, and neonatal hemolytic disease, eluting agents, quality controls for screening and cross-matching, medical centrifuges, and reagent card incubators. The company was founded on July 16, 2001 and is headquartered in Changchun, China.